FDA Adverse Event Injury Summary report: N

XEN 45 GTS

MDR report key: 25021545 · Received April 28, 2026

Report

Report Number
3011299751-2026-00055
Event Type
Injury
Date Received
April 28, 2026
Date of Event
April 15, 2026
Report Date
April 28, 2026
Manufacturer
ALLERGAN (IRVINE)
Product Code
KYF
PMA / PMN Number
K161457
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

ARTICLE CITATION: KIESSLING, DAVID, ET AL. ¿CYSTOID MACULAR EDEMA AS A PREDICTOR FOR BLEB FAILURE AFTER COMBINED XEN45 GEL STENT IMPLANTATION WITH PHACOEMULSIFICATION.¿ GRAEFE¿S ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 15 APR. 2026, HTTPS://DOI.ORG/10.1007/S00417-026-07213-4. FURTHER INFORMATION REGARDING EVENT, PRODUCT, OR PATIENT DETAILS HAS BEEN REQUESTED. NO ADDITIONAL INFORMATION IS AVAILABLE AT THIS TIME. THE EVENT IS A PHYSIOLOGICAL COMPLICATION AND ANALYSIS OF THE DEVICE GENERALLY DOES NOT ASSIST ABBVIE IN DETERMINING A PROBABLE CAUSE FOR THIS EVENT. THE EVENT IS A KNOWN POTENTIAL ADVERSE EVENT ADDRESSED IN THE PRODUCT LABELING.

Description of Event or Problem · 0

REVIEW OF THE ARTICLE "CYSTOID MACULAR EDEMA AS A PREDICTOR FOR BLEB FAILURE AFTER COMBINED XEN45 GEL STENT IMPLANTATION WITH PHACOEMULSIFICATION" FROM THE JOURNAL GRAEFES ARCHIVE FOR CLINICAL EXPERIMENTAL OPHTHALMOLOGY NOTED THE FOLLOWING POSTOPERATIVE EVENTS "15 EYES HAD CYSTOID MACULAR EDEMA CONFIRMED VIA OPTICAL COHERENCE TOMOGRAPHY (OCT) AND WERE PRIMARILY TREATED WITH MONODEX EYE DROPS FIVE TIMES DAILY, IN 3 EYES MONODEX DID NOT RESOLVE CME AND REQUIRED DIPROSONE 7 MG/ML INJECTION DURING BLEB REVISION; 28 EYES HAD BLEB FAILURE REQUIRING CONJUNCTIVAL REVISION SURGERY (INCLUDING THE CME CASE); UNKNOWN EYES REQUIRED ANTI-GLAUCOMA MEDICATION."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1075279 XEN 45 GTS IMPLANT, EYE VALVE KYF ALLERGAN (IRVINE) NI

Patients

Seq Age Sex Outcome Treatment
1 73 YR Unknown Required Intervention